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Abstract 
Extensive research over the past decades has identified integrins to be the primary transmembrane 
receptors that enable cells to respond to external mechanical cues. We reveal here a mechanism 
whereby syndecan-4 tunes cell mechanics in response to localised tension via a coordinated 
mechanochemical signalling response that involves activation of two other receptors: epidermal 
growth factor receptor, and β1 integrin. Tension on syndecan-4 induces cell-wide activation of the 
kindlin-2/β1 integrin/RhoA axis in a PI3K dependent manner. Furthermore, syndecan-4 mediated 
tension at the cell-extracellular matrix interface is required for YAP activation. Extracellular tension 
on syndecan-4 triggers a conformational change in the cytoplasmic domain, the variable region of 
which is indispensable for the mechanical adaptation to force, facilitating the assembly of a 
syndecan-4/α-actinin/F-actin molecular scaffold at the bead adhesion. This mechanotransduction 
pathway for syndecan-4 should have immediate implications for the broader field of 
mechanobiology. 
Keywords: syndecan-4, mechanotransduction, mechanobiology, integrin, kindlin, alpha-actinin, F-
actin, RhoA, PI3K, YAP. 
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Syndecans belong to a family of four transmembrane proteoglycan adhesion receptors. Among 
them, syndecan-4 is the only family member that is ubiquitously expressed across nucleated cells 
and enriched in focal adhesions1. The extracellular domain of syndecan-4 bears heparan sulphate 
chains that bind to ECM proteins containing heparin binding domains (e.g. fibronectin) in addition 
to growth factors2. The transmembrane domain drives dimerization, and the cytoplasmic domain 
promotes binding to focal adhesion components and intracellular kinases3. Syndecan-4 acts 
synergistically with integrins to regulate substrate adhesion, focal adhesion assembly and 
cytoskeletal organisation3-5. Syndecan-4 also complexes with integrin α5β1 to cooperatively bind 
Thy-1 (CD90), forming a unique dynamic catch bond which strengthens under force to mediate 
adhesion signalling6. Much like integrins, syndecan-4 provides a direct mechanical linkage from the 
extracellular matrix (ECM) to the actin cytoskeleton and is thus well positioned to support force 
transmission and act as a mechanotransducer.  
 
Syndecan-4 null mice exhibit delayed wound healing7, while syndecan-4 null cells show impaired 
contractility, cytoskeletal organisation, and immature focal adhesions8-12, all suggestive of 
mechanosensation deficits. Indeed, studies in endothelial cells under fluid shear have implicated 
syndecan-4 in mechanotransduction both in vitro13,14 and in vivo15,16. Syndecan-4 has additionally 
been shown to respond to directly applied mechanical tension, activating mitogen-activated protein 
kinase (MAPK) and protein kinase C-α (PKC-α) signalling17,18. These studies suggest syndecan-4 
is directly involved in mechanotransduction, however its specific role and the underlying molecular 
mechanisms are unknown. Here, we have combined biophysical, cell biology and computational 
techniques to reveal a role for syndecan-4 in regulating cell mechanics through a previously 
unidentified mechanotransduction pathway requiring synergistic integrin activation. 
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Results 
Tension on syndecan-4 induces adaptive cell stiffening 
Tensional force on mechanosensitive receptors, such as integrins, triggers rapid cytoskeletal 
remodelling and adaptive cellular stiffening19. This response has also been observed in cell-cell 
junction proteins, E-cadherin and platelet endothelial cell adhesion molecule-1 (PECAM-1)20,21, and 
nuclear envelope component nesprin-122. To investigate if syndecan-4 acts as a mechanotransducer, 
we used electromagnetic tweezers to apply repeated localised mechanical tension to the syndecan-4 
receptor on cells plated on fibronectin via ligand-coated magnetic beads, while tracking bead 
displacement (Fig. 1a). To ensure specificity of the cellular response to force, we coated the 
magnetic beads with an anti-syndecan-4 antibody (Anti-Sdc4) that binds specifically to the 
ectodomain of syndecan-4 core protein (Supplementary Figs. 1,2). Application of 12 successive 1 
nN force pulses to Anti-Sdc4 beads triggered an adaptive increase in cellular stiffness evident as a 
decrease in bead displacement, reaching a relative displacement reduction of 37% by the 12th pulse 
(Fig. 1b,c, Supplementary Fig. 3). To mimic physiological ligand binding to the heparan sulphate 
chains of syndecan-4, we used beads coated with the 40 kDa α-chymotryptic fragment of 
fibronectin which contains the CS-1 heparin binding domain (FN-HBD) and does not bind 
integrins23. In this case we also observed a reduction in the amplitude of bead oscillation (Fig. 1c). 
Binding to the heparan sulphate chains of syndecan-4 was also achieved using fibronectin coated 
beads which were treated with an anti-fibronectin antibody (clone 3E3) which blocks the RGD 
integrin binding site but leaves the heparin binding domain available23. Again, we observed a 
decrease in the amplitude of bead oscillation indicative of adaptive cell stiffening (Supplementary 
Fig. 5). To ensure this response is specific to syndecan-4, we used the same force protocol on beads 
coated with poly-L-lysine (PLL) which binds the cell membrane non-specifically via electrostatic 
interactions, and an antibody that binds the extracellular domain of transferrin receptor protein-1 
(Anti-TfR1), previously shown to be non-responsive to tensional force19. A reduction in bead 
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displacement over the 12 pulses was not observed in either case (Fig. 1c). These results demonstrate 
that tensional force applied specifically to syndecan-4 core protein or its associated heparan 
sulphate chains leads to an adaptive cellular stiffening response.  
 Using a battery of pharmacological inhibitors, we mechanistically investigated this syndecan-4-
mediated mechanotransduction response. Pre-treatment of cells with the F-actin polymerisation 
inhibitor latrunculin A prior to force application prevented the stiffening response, with no 
reduction in relative bead displacement by force pulse 12 (Fig. 1d). Likewise, pharmacological 
inhibition of Rho with C3 transferase or Rho-associated protein kinase (ROCK) with Y-27632 also 
blocked a reduction in bead displacement (Fig. 1d), demonstrating that a functional contractile 
cytoskeleton is required for syndecan-4 mediated cell stiffening. Phosphoinositide 3-kinase (PI3K) 
activation has been shown to play a role in cell-cell junction mediated cellular stiffening20,21. 
Intriguingly, syndecan-4 mediated stiffening also showed a dependency on PI3K, as treatment with 
the PI3K inhibitor LY-294002 abrogated the cell’s mechanical adaptation to force (Fig. 1d). PI3K 
activation produces freely diffusible phosphatidylinositol-3,4,5-trisphosphate (PIP3) that acts as a 
lipid second messenger to propagate signalling cascades throughout the cell24. A major downstream 
effector of PI3K/PIP3 signalling is AKT. However, selective inhibition of AKT using SH-5 did not 
prevent cell stiffening in response to force (Fig. 1d), suggesting PI3K acts via an alternative 
mechanotransduction pathway. 
We next investigated whether tension on syndecan-4 activates PI3K activity through the generation 
of PIP3 in cells expressing a green fluorescent protein (GFP) reporter containing the pleckstrin 
homology (PH) domain of AKT (PH-AKT-GFP) which binds PIP3. Sustained 1 nN tension for 60 s 
on syndecan-4 resulted in elevated PI3K activity apparent by the accumulation of PH-AKT-GFP 
around the bead (Fig. 1e). No such accumulation was observed with the same force applied to PLL-
6 
 
coated beads (Supplementary Fig. 6), indicating that force-induced PI3K activation is specific to 
syndecan-4. 
 
Receptor tyrosine kinases can activate PI3K in response to ligand stimulation24. Epidermal growth 
factor receptor (EGFR) is a receptor tyrosine kinase that is known to form a complex with 
syndecan-425. Activated EGFR recruits GRB2-associated-binding protein 1 (GAB1), which 
becomes tyrosine phosphorylated at sites that recruit the SH2 domains of the PI3K p85 subunit, 
providing an indirect mechanism for EGFR to activate PI3K26. To investigate how tension on 
syndecan-4 regulates PI3K activity, we treated cells with the EGFR inhibitor Gefitinib prior to 
application of sustained tension to syndecan-4 bound beads; this treatment abolished cell stiffening 
(Supplementary Fig. 7). As EGFR can be activated by both ligand-dependent and -independent 
mechanisms, we treated PH-AKT-GFP expressing cells with a neutralising anti-EGF antibody 
which inhibits EGF ligand-dependent EGFR signalling27. This treatment prevented force induced 
PI3K activation (Fig. 1f) and these cells failed to exhibit a stiffening response (Supplementary Fig. 
7) upon force application to syndecan-4. EGF has been shown to sensitise mechano-responsiveness 
by enhancing strain mediated mechanotransduction28, and increasing rigidity sensing29, while the 
dependence of adaptive stiffening on ligand activation of EGFR and PI3K is analogous to a 
mechanotransduction pathway mediated by E-cadherin21. Hence, ligand-dependent activation of 
EGFR may amplify syndecan-4 mechanotransduction to facilitate downstream PI3K signalling. 
Collectively, these results demonstrate that syndecan-4 is a cellular mechanotransducer that tunes 
cell mechanics in response to localised tension via an adaptive stiffening response involving EGFR 
and PI3K mediated regulation of cytoskeletal remodelling via Rho.  
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Tension on syndecan-4 drives cell-wide focal adhesion growth 
Most ECM molecules contain binding sites for both integrins and syndecans and there is substantial 
evidence of a clear synergy between the two receptor families4. Cooperative signalling from both 
integrins and syndecans potentiates force transduction and is required for the assembly of focal 
adhesion complexes, associated stress fibre formation, regulation of cytoskeletal dynamics and 
directional migration3-5,30. 
 
We thus asked if localised tension on syndecan-4 can actively recruit focal adhesion proteins talin 
and kindlin under force. These two families of FERM-domain proteins bind the cytoplasmic tail of 
integrins, recruit cytoskeletal and signalling proteins involved in mechanotransduction and 
synergise to activate integrin binding to the extracellular matrix31. Anti-Sdc4 magnetic beads 
adhered to the apical surface of cells on fibronectin prior to treatment with PI3K inhibitor LY-
294002 or vehicle (DMSO). Using a permanent magnet, a sustained ~200 pN tensile force was 
applied to syndecan-4 for 5 min (Fig. 2a). In the absence of force, talin-1 and kindlin-2 
immunofluorescent staining around the bead was limited. With sustained force application to 
syndecan-4, both talin-1 and kindlin-2 were recruited to the bead adhesion leading to an approx. 2-
fold increase in staining intensity (Vehicle, Fig. 2b,c). However, when PI3K was inhibited, talin-1 
and kindlin-2 were not recruited (Fig. 2b,c).  
 
When we assessed talin-1 and kindlin-2 localisation at the basal membrane where the cell contacts 
the fibronectin ECM, we found a cell-wide increase in the size and number of talin-1 and kindlin-2 
containing focal adhesions after sustained force application to apical syndecan-4 (Vehicle, Fig. 
2d,e). PI3K inhibition similarly abrogated the force-induced recruitment of talin-1 and kindlin-2 to 
focal adhesions at the basal surface (Fig. 2d,e). This implies that localised force on syndecan-4 
triggers PI3K dependent, cell-wide activation and growth of talin-1 and kindlin-2 enriched focal 
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adhesions to induce a global cellular response even at sites distal from the point of force 
application.  
 
PIP3 binding to kindlin-2 mediates integrin activation 
The cell-wide growth of talin-1 and kindlin-2 containing focal adhesions prompted us to investigate 
if force on syndecan-4 leads to inside-out activation of integrin receptors. Binding of the talin 
FERM domain to the β integrin tail provides one key activation signal, but kindlin-2 also plays a 
central role in this process31. Unlike talin, the FERM domain of kindlin-2 contains a PH domain 
with a binding site for PIP3, which promotes talin-mediated integrin activation32. Biophysical 
induction of PI3K activity has been implicated in regulating integrin activation, although the 
molecular mechanisms have not been studied20,21.  
 
We used a permanent magnet to apply sustained ~200 pN tension for 5 min to syndecan-4 in cells 
plated on fibronectin. Total internal reflection fluorescence (TIRF) imaging of the basal surface of 
cells revealed a cell-wide activation of β1 integrins upon force application to syndecan-4, evident as 
an increase in the size of adhesions positive for the active conformation of integrin β1 (Fig. 3a,b). 
This is consistent with our findings showing PI3K-dependent cell-wide growth of kindlin-2 and 
talin-1 enriched focal adhesions (Fig. 2d,e). The force-induced increase of activated β1 integrins 
mirrored the levels induced by Mn2+ treatment (without force), which shifts integrins into a high-
affinity conformation, whereas removal of divalent cations with EDTA treatment reduced β1 
integrin activation (Fig. 3a,b). We observed no change in the levels of total integrin β1 
incorporation into adhesions under the same conditions (Supplementary Fig. 8). 
 
Biochemical and structural studies have affirmed that the interaction of PIP3 with kindlin-2 is 
critical to regulating the latter’s function by promoting membrane anchoring and integrin 
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activation32,33. We thus asked whether force on syndecan-4 regulates integrin activation through an 
interaction between kindlin-2 and PIP3. siRNA-mediated knockdown of kindlin-2 suppressed the 
previously observed activation of β1 integrins under force (Fig. 3c,d). Re-expression of a kindlin-2 
mutant (K390A), lacking phosphoinositide binding activity34, into kindlin-2 knockdown cells failed 
to recover cell-wide activation of β1 integrins in response to tension on syndecan-4 (Fig. 3c,d, 
Supplementary Fig. 9). Force-induced activation of β1 integrins was rescued in kindlin-2 
knockdown cells re-expressing wild type kindlin-2. Collectively, these results indicate that 
activation of PI3K in response to localised tension on syndecan-4 triggers cell-wide inside-out 
activation of β1 integrins through PIP3 interaction with kindlin-2 at focal adhesions. 
RhoA activation requires additional ECM-integrin ligation 
While we have shown that Rho is required for syndecan-4 mediated adaptive cell stiffening (Fig. 
1d), the role that RhoA plays in this syndecan-4 mediated mechanotransduction pathway remains 
unclear. For this reason, we measured activation levels of RhoA and found that sustained ~200 pN 
tensional force on syndecan-4 increased RhoA activation in a time-dependent manner (Fig. 4a). We 
next sought to determine whether the observed cell-wide basal activation of β1 integrins and growth 
of focal adhesions is a consequence, or an essential element in the syndecan-4 mechanotransduction 
cascade leading to adaptive cell stiffening. Syndecan-4 is known to work in concert with integrins 
to regulate focal adhesion growth and cytoskeletal organisation4. Thus, we investigated whether 
force-induced RhoA activation and adaptive cell stiffening downstream of tension on syndecan-4 
requires engagement of integrins. 
Fibronectin contains domains that can engage both integrins and syndecans via their heparan 
sulphate chains. The integrin-binding domain of fibronectin lies within the 10th type III module 
(FN-III10) containing the Arg-Gly-Asp (RGD) motif, while the heparin binding domain lies within 
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type III repeats 12-14 (FN-III12-14). We thus treated cells adherent to fibronectin with an anti-
fibronectin antibody (clone 3E3) which blocks the RGD integrin binding site in FN-III10 (ref. 23) to 
prevent integrin ligation and the formation of new fibronectin connections. We applied a 1 nN 
pulsatile force to syndecan-4 and observed adaptive cell stiffening in the presence of an isotype 
control IgG1-κ antibody (Fig. 4b). However, blocking the integrin-binding domain of fibronectin 
(Anti-FN 3E3 Ab) inhibited the stiffening response (Fig. 4b); suggesting that syndecan-4 mediated 
force transduction requires engagement of new β1 integrins with the underlying fibronectin 
substrate. Indeed, when syndecan-4 on cells in the presence of the same antibodies was subjected to 
sustained force of ~200 pN for 5 min using a permanent magnet, immunofluorescent staining 
revealed enhanced engagement of new β1 integrins in the presence of the IgG control antibody 
which did not occur when the RGD integrin binding site was blocked (Anti-FN 3E3 Ab; Fig 4c,d). 
Consistent with this, blocking of fibronectin’s RGD integrin binding site also suppressed RhoA 
activation upon sustained force application on syndecan-4 (Fig. 4e). No changes in cell spread area 
were observed upon blocking of the RGD integrin binding site (Supplementary Fig. 11). Analogous 
but slightly attenuated adaptive stiffening and RhoA responses were observed in cells on collagen 
type I (Supplementary Fig. 12), indicating that RGD-specific integrin ligation is not a requirement 
for RhoA induction. These results demonstrate that activation of RhoA in response to tension on 
syndecan-4 requires the engagement of new integrin-ECM connections. 
 
Syndecan-4 mediated tension regulates YAP activation 
RhoA activity and cytoskeletal tension are known actors in various mechanotransduction pathways 
which lead to changes in gene expression impacting cell function35. Yes-associated protein (YAP) is 
a transcription coactivator with a well-established role in converting biophysical inputs into gene 
expression signatures36. We sought to investigate whether syndecan-4 modulates YAP activity to 
regulate gene expression and cell function. 
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Wild-type (WT) and syndecan-4 null (Sdc4-/-) mouse embryonic fibroblasts (MEFs) were plated 
onto fibronectin-coated glass or 25 kPa polyacrylamide gels. WT cells adopted a spread 
morphology with prominent F-actin stress fibres and a high nuclear:cytoplasmic YAP ratio (Fig. 
4f,g, Supplementary Fig. 13). In contrast, YAP was mostly cytoplasmic in Sdc4-/- cells, and while 
these cells adhered and spread as normal, they lacked F-actin stress fibres, suggestive of lower 
cytoskeletal tension (Fig. 4f,g, Supplementary Fig. 13). Nuclear localisation of YAP could be 
partially rescued with the expression of WT syndecan-4-GFP in Sdc4-/- cells (Fig. 4f,g). These 
syndecan-4 dependent changes in YAP activity altered the mRNA expression of established YAP 
target genes as both connective tissue growth factor (Ctgf) and ankyrin repeat domain 1 (Ankrd1) 
were found to be downregulated in Sdc4-/- cells compared to WT cells (Fig. 4h). 
 
The role of syndecan-4 in the regulation of YAP activity is not limited to fibronectin, as we also 
observed a reduction in the ratio of nuclear:cytoplasmic YAP in Sdc4-/- compared to WT cells 
when plated on collagen type I (Supplementary Fig. 14). Consistent with the attenuated syndecan-4 
force mediated cell-stiffening and RhoA activation observed in cells on collagen type I as opposed 
to fibronectin, both WT and Sdc4-/- cells exhibited decreased nuclear:cytoplasmic YAP on collagen 
type I compared to fibronectin (Supplementary Fig. 14). These results suggest that syndecan-4-
mediated tension at the cell-ECM interface is essential for YAP transcriptional signalling. 
 
Syndecan-4’s V-region is required for mechanotransduction 
We next sought to identify the molecular mechanism through which tension applied to the 
extracellular domain of syndecan-4 provokes a mechanoresponse. The cytoplasmic domain of 
syndecan-4 regulates interactions with scaffolding and signalling proteins and likely plays a role in 
mediating syndecan-4 mechanotransduction. It comprises a pair of conserved (C1 and C2) regions 
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common to all syndecan isoforms, separated by a variable (V) region specific to syndecan-4 (Fig. 
5a).  
 
Induction of protein phosphorylation is one of the first events that occurs when mechanical force is 
applied to cells37. We investigated the tyrosine residue Y180 in the C1 region of syndecan-4 which 
has been identified as a major phosphorylation site controlling integrin trafficking, focal adhesion 
dynamics and migratory behaviour30. Pulsatile 1 nN tension was applied to syndecan-4 bound beads 
attached to MEFs expressing either a syndecan-4 mutant which could not be phosphorylated on 
Y180 (Sdc4Y180L), or a phospho-mimetic syndecan-4 that emulates c-Src-mediated 
phosphorylation of the Y180 residue (Sdc4Y180E, Fig. 5b)30. The observed reduction in relative 
bead displacement demonstrated that both phospho-null Sdc4Y180L and phospho-mimetic 
Sdc4Y180E cells were able to stiffen under force; indicating that the phosphorylation status of 
Y180 is dispensable for syndecan-4 mechanotransduction (Fig. 5c). 
 
The conserved C2 domain contains a PDZ-binding site that interacts with PDZ-domain containing 
proteins, which coordinate receptor clustering, exosome biogenesis and the formation of 
connections to the actin cytoskeleton, mainly via calcium/calmodulin-dependent serine protein 
kinase (CASK)38,39. We expressed a truncated syndecan-4 core protein lacking the C-terminal C2 
(EFYA) domain (Sdc4∆195Ε, Fig. 5b, Supplementary Fig. 16) in syndecan-4 null MEFs. Deletion 
of the C2 domain had no discernible effect on syndecan-4 mediated cell stiffening (Fig. 5c).  
 
The syndecan-4 specific V-region interacts with both PKC-α and the phospholipid 
phosphatidylinositol (4,5) bisphosphate (PIP2) to transduce downstream signals for cytoskeletal 
organisation39,40. The V-region further associates with the actin-crosslinking protein α-actinin to 
provide a direct mechanical link to the cytoskeleton41.  MEFs expressing a syndecan-4 core protein 
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truncated in the centre of the V-region (Sdc4∆187I, Fig. 5b, Supplementary Fig. 16) were unable to 
mount a stiffening response upon mechanical stimulation of syndecan-4 (Fig. 5c). The Sdc4∆187I 
truncation deletes the binding site for PKC-α and α-actinin41,42. Previously, V-region truncation at 
this site has been associated with defects in cytoskeletal organisation, stress fibre assembly and 
focal adhesion formation, as well as inhibited myofibroblast differentiation8,11. As expected, 
adaptive cell stiffening was observed when tension was applied to MEFs expressing wild type 
syndecan-4 (Sdc4WT; Fig. 5c, Supplementary Fig. 16). These results indicate that interactions 
between the V-region of syndecan-4’s cytoplasmic domain and its binding partners α-actinin and/or 
PKC-α  is necessary to initiate mechanotransduction and mechanical adaptation to force. 
 
External tension alters cytoplasmic syndecan-4 conformation 
To investigate the effect of tensional force on syndecan-4 at the molecular level, we conducted 
molecular dynamics (MD) simulations. The system consisted of homodimeric transmembrane and 
cytoplasmic domains of syndecan-4 embedded within a membrane bilayer containing a mixture of 
lipids, including PIP2. In equilibrium 50 ns MD simulations (no applied force) syndecan-4 structure 
showed no major conformational changes in the cytoplasmic domain (Fig. 5d). Constant force 
pulling at 50 pN applied to the extracellular side of syndecan-4 caused directed movement of the 
cytoplasmic domain towards the membrane (Fig. 5d). Root mean square fluctuations (RMSF) of Cα 
show that the transmembrane helices in the hydrophobic core of the membrane are mostly stable 
during the simulation while the C-terminal residues (C2 region) are more flexible (Fig. 5e,f). We 
chose the lysine residue K190, as one of the most stable positions in the V region, to monitor the 
conformational changes of the cytoplasmic domain on the membrane plane (Fig. 5g). Directed 
movement of the cytoplasmic domain led to association of syndecan-4 with the membrane, where 
electrostatic interactions between lysine residues and heads of PIP2 lipids took place. Using constant 
force pulling at 50 pN and 100 pN over a 50 ns simulation, we observed similar tilting of the 
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cytoplasmic domain towards the plasma membrane (Supplementary Figs. 17,18). The use of 25 pN 
constant force caused a similar but slower conformational change within the cytoplasmic domain 
with 100 ns required to observe an effect like that seen at 50 ns under 50 pN. Using a higher force 
magnitude of 200 pN caused increased sliding of the protein through the membrane, resulting in 
non-directed movement of the cytoplasmic domain (Supplementary Fig. 18). 
 
The observed force-dependent orientation of the cytoplasmic domain, leading to membrane 
interactions, may be important in the modulation of intracellular associations between syndecan-4 
and its binding partners, including the scaffolding protein α-actinin which is known to interact with 
the region. 
 
Force stabilises a syndecan-4/α-actinin/F-actin linkage 
We next sought to investigate how the force-induced conformational change in the cytoplasmic V 
region is linked to syndecan-4 mechanosignalling. α-actinin, via spectrin repeat 4 (SR4) in its rod 
domain, interacts with syndecan-4’s cytoplasmic V-region to establish a mechanical linkage 
between syndecan-4 and the actin cytoskeleton (Fig. 6a)10. We used siRNA to knockdown the 
endogenous expression of the predominant α-actinin isoforms — α-actinin-1 (Actn1) and α-actinin-
4 (Actn4; siActn1Actn4) — in MEFs, and subsequently expressed fluorescently tagged α-actinin-1 
(ACTN1)-GFP which localised to focal adhesions throughout the cell (Supplementary Fig. 19). 
When 1 nN sustained tension was applied to syndecan-4 bound beads with magnetic tweezers, 
accumulation of ACTN1-GFP could be observed in a region of interest surrounding the magnetic 
bead after 60 s (Fig. 6b,c). 
 
Further to this finding, MEFs with siRNA-mediated knockdown of α-actinin-1 and -4 
(siActn1Actn4) were unable to exhibit an adaptive stiffening response to 1 nN pulsatile tension 
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applied on syndecan-4 (Fig. 6d). While adaptive stiffening could be rescued through re-expression 
of full length ACTN1-GFP into α-actinin depleted cells (siActn1Actn4 + ACTN1-GFP), re-
expression of an α-actinin mutant, where the actin-binding domain (ABD) was deleted 
(siActn1Actn4 + ACTN1-∆ABD-GFP)43, failed to rescue the adaptive stiffening response to tension 
on syndecan-4 (Fig. 6d). Cells transfected with non-targeting control siRNA (siNT) maintained the 
adaptive stiffening response (Fig. 6d). 
 
These results imply that force on syndecan-4 stabilises the assembly of a syndecan-4/α-actinin/F-
actin molecular scaffold at the cell-ECM junction to facilitate force transmission and downstream 
syndecan-4 mechanosignalling (Fig. 6e).  
 
 
Discussion 
It has previously been reported that syndecan-4 can initiate mechanochemical signalling without the 
need for other ECM receptors, exhibiting vinculin recruitment and activation of ERK17 and PKC-
α18. Syndecan-4 is also implicated in flow sensing in endothelial cells that ultimately confers 
atheroprotective effects15,16. We provide evidence that while syndecan-4 is capable of initiating 
mechanotransduction as a lone ECM receptor, the underlying signalling network integrates distinct 
plasma membrane receptors; EGFR which augments the mechanoresponse and β1 integrins which 
are required for adaptive cellular stiffening. Our results demonstrate that localised tension on 
syndecan-4 initiates an adaptive stiffening response through a mechanosignalling cascade that 
requires synergistic cell-wide activation of β1 integrins and formation of new integrin-ECM 
connections, followed by subsequent RhoA induced actomyosin contractility. We have established 
a force-dependent syndecan-integrin crosstalk with these two mechanosensors acting synergistically 
to induce RhoA activation, adaptive stiffening and YAP transcriptional signalling. 
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While adaptive cell stiffening and local adhesion strengthening are common mechanosensitive 
responses shared among integrins and cadherins, perhaps the most striking aspect of syndecan-4 
mechanosensing is how a localised force can elicit a cell-wide response as evidenced by the global 
growth of focal adhesions and activation of integrins. Intriguingly, our data suggest syndecan-4 
mechanosignalling is both chemically and mechanically propagated throughout the cell via 
diffusion of PIP3 lipid second messengers and mechanical transmission through the tensile 
cytoskeleton via a syndecan-4/α-actinin/F-actin molecular scaffold. This contrasts with the 
localised stiffening response which occurs when force is applied to integrin adhesions. 
 
The dependence of adaptive stiffening on PI3K and integrins parallels in many ways the 
mechanotransduction pathways mediated by PECAM-1 in endothelia20 and E-cadherin in 
epithelia21. Localised tension on PECAM-1 elicits a cell-wide mechanotransduction response20, 
which is mediated by a mechanosensory complex additionally comprising vascular endothelial cell 
(VE-) cadherin and vascular endothelial growth factor receptor 2 (VEGFR2) which activates 
PI3K44. The analogous global mechanotransduction response observed for these distinct 
mechanoreceptors—syndecan-4, PECAM-1 and E-cadherin—suggests that the kindlin-integrin-
RhoA pathway leading to adaptive cell stiffening may be a conserved mechanism employed by 
numerous mechanosensory complexes. 
 
The role of integrin-mediated mechanosignalling has been the subject of intense investigation, 
however a more integrative approach that includes syndecan-4 as a mechanosensor could unearth 
new disease mechanisms. In summary, our results suggest that syndecan-4 is a key cellular 
mechanotransducer that responds to localised mechanical tension by eliciting a global response that 
regulates cell mechanics via cell-wide engagement of a PIP3/kindlin-2/integrin/RhoA axis as well as 
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serving as a potent modulator of YAP activity with important implications for 
mechanotransduction, syndecan biology, and cell-ECM interactions. 
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Methods 
Cell culture and reagents 
Primary human culture activated pancreatic stellate cells (PSCs; Caltag Medsystems SC-3830) were 
cultured at 37°C, 5% CO2 in Dulbecco’s modified Eagle’s medium/F12 Ham (DMEM/F12; D8437) 
with 2% foetal bovine serum (FBS), 100 U ml-1 penicillin-100 µg ml-1 streptomycin (all Sigma-
Aldrich) and 2.5 µg ml-1 amphotericin B (Gibco) and used at passage 4-8. Immortalised mouse 
embryonic fibroblast (MEF) cell lines were a gift from Dr Mark Morgan and included wild type, 
syndecan-4 -/- (ref. 45), and lines expressing mutant syndecan-4 phospho-null Y180L, and 
phospho-mimetic Y180E (ref. 30). MEFs were cultured at the large T-antigen permissive 
temperature of 33°C in high glucose DMEM (Gibco) with 10% FBS and 100 U ml-1 penicillin-100 
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µg ml-1 streptomycin (all Sigma-Aldrich). All experiments and treatments were conducted at 37°C. 
Cells were plated on substrates coated with 2.5 µg ml-1 fibronectin or 10 µg ml-1 collagen type I 
(Sigma-Aldrich). 25 kPa polyacrylamide gels were fabricated as described previously46. Expression 
of syndecan-4 in MEFs and PSCs was confirmed using western blot (Supplementary Fig. 22). 
 
Cells were treated with 0.5 µM latrunculin A (Merck 428026) for 1 h to inhibit F-actin 
polymerisation, with 2 µg ml-1 C3 transferase (Cytoskeleton Inc.) for 4 h to inhibit Rho, with 10 µM 
Y-27632 (Merck 688001) for 1 h to inhibit ROCK, with 30 µM LY-294002 (Sigma Aldrich L9908) 
for 1 h to inhibit PI3K, with 10 µM SH-5 (Abcam ab141442) for 1 h to inhibit AKT, and with 15 
µM Gefitinib (Santa Cruz Biotechnology sc-202166) for 2 h to inhibit EGFR. Cells were treated 
with 1 mM MnCl2 (Fisher Scientific) for 30 min to induce integrin activation, and 2 mM EDTA 
(Sigma Aldrich) for 30 min to sequester divalent ions responsible for integrin activation. Cells were 
treated with 5 µg ml-1 mouse anti-human EGF antibody, clone 10825 (R&D Systems MAB236; 
RRID:AB_2095960) to neutralise EGF. Cells plated on fibronectin substrates were treated with 20 
µg ml-1 mouse anti-fibronectin antibody (cell attachment fragment), clone 3E3 (Merck MAB88916; 
RRID:AB_95479), for 30 min to block integrin ligation to RGD. Mouse IgG1-κ, clone MOPC-21 
(Merck MABF1081Z; RRID:AB_395252) was used as an isotype control. 
 
PSCs were transfected by electroporation using the Neon Transfection system (Thermo Fisher 
Scientific) with one pulse of 1,300 V for 30 ms. WT and Sdc4-/- MEF cell lines were transfected 
using Lipofectamine 3000 (Thermo Fisher Scientific). After transfection, cells were allowed 
recover in antibiotic-free media for 24 h. Experiments were conducted 48 h post transfection. Cells 
were transfected with siRNA targeting kindlin-2 (Mig-2, sc-106786), both α-actinin-1 (Actn1, sc-
43096) and α-actinin-4 (Actn4, sc-43102), or non-targeting control (sc-37007, all Santa Cruz 
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Biotechnology). The PH-AKT-GFP plasmid was a gift from Tamas Balla (Addgene plasmid 51465; 
RRID:Addgene_51465)47. The kindlin-2-GFP plasmid was a gift from Jun Qin32. The kindlin-2-
K390A-HA plasmid lacking phosphoinositide binding activity was a gift from Chuanyue Wu34. The 
syndecan-4 C2 truncation plasmid Sdc4∆195E (ref. 11) and the syndecan-4 V-domain truncation 
plasmid Sdc4∆187I (ref. 8) were gifts from John Couchman. The α-actinin-1 (ACTN1)-GFP 
plasmid was a gift from Carol Otey (Addgene plasmid 11908; RRID:Addgene_11908)48 and α-
actinin-1 (ACTN1)-∆ABD-GFP (Addgene plasmid 66935; RRID:Addgene_66935) was as 
described previously43. Control empty vector pEGFP-N1 was from Clontech. siRNA mediated 
knockdown of kindlin-2 was confirmed with immunofluorescent staining (Supplementary Fig. 9) 
and knockdown of α-actinin confirmed using western blot against α-actinin-4 (Supplementary Fig. 
19). Plasmid expression was assessed based on GFP signal or immunofluorescent staining for the 
HA tag (Supplementary Fig. 16). 
Magnetic bead preparation 
Antibodies and ECM ligands were coupled to 4.5 µm epoxide paramagnetic beads (Dynabeads M-
450 Epoxy, Thermo Fisher Scientific) according to manufacturer’s instructions. Beads were washed 
twice in 0.1 M sodium phosphate buffer, pH 7.4, before coupling with 40 µg antibody or ECM 
ligand per 8×107 beads in 0.1 M sodium phosphate buffer pH 7.4 for 30 min followed by addition of 
0.1% bovine serum albumin (BSA) and further incubation for 16 h at room temperature with gentle 
rotation throughout. Beads were washed and subsequently stored in 0.1% BSA-phosphate buffered 
saline (PBS) pH 7.4 at 4°C. Beads were coated with mouse anti-syndecan-4 antibody, clone 5G9 
(Santa Cruz Biotechnology sc-12766; RRID:AB_628314), poly-L-lysine, fibronectin (both Sigma-
Aldrich), the 40 kDa α-chymotryptic fragment of fibronectin which contains the CS-1 heparin 
binding domain (Merck F1903), or mouse anti-transferrin receptor-1, clone 3B8 2A1 (CD71, Santa 
Cruz Biotechnology sc-32272; RRID:AB_627167). For experiments, ligand-coated magnetic beads 
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were resuspended in media and incubated with cells for 30 min at 37°C. Cells were briefly washed 
with PBS to remove unbound beads prior to force application. Syndecan-4 binding to functionalised 
beads was confirmed by immunofluorescent staining (Supplementary Fig. 1) and isolation of the 
bead adhesion complex in cell lysates and subsequent western blotting (Supplementary Fig. 2). 
 
Force application to cell bound beads 
A custom-built electromagnetic tweezers apparatus fitted to an inverted microscope (Eclpise Ti, 
Nikon) was used to apply controlled pulsatile forces to individual ligand-coated magnetic beads 
attached to cells plated onto fibronectin or collagen type I coated glass bottomed dishes (Fluorodish, 
World Precision Instruments). Application of the pulsatile regimen consisting of 12 pulses of 1 nN 
force for 3 s with intervening 4 s periods of relaxation was achieved through a LabVIEW interface 
(National Instruments). On force application, bead displacements were recorded with a high-speed 
CMOS camera (Andor Neo sCMOS, Oxford Instruments) at 50 Hz using a 40× 0.6 NA air objective 
(Nikon). Displacement was tracked using a custom-written particle tracking algorithm in MATLAB 
that detects the intensity-weighted centroid of the bead with subpixel accuracy. The electromagnetic 
tweezers device was calibrated before the experiments using a fluid of known viscosity. Beads that 
showed displacements of less than 50 nm (detection resolution) and loosely bound beads were not 
selected for analysis. Application of sustained 1 nN force was also applied to cells for 60 s with 
concurrent imaging of GFP localisation around the attached bead. To apply a constant force on a 
larger number of beads, we used a permanent neodymium magnet that allowed us to apply a vertical 
tensile force on the beads with magnitudes of approx. 200 pN. 
 
Immunofluorescent staining and image analysis 
Cells were seeded on ECM coated coverslips for immunofluorescent staining. Following pertinent 
treatment, cells were fixed with 4% paraformaldehyde (Sigma-Aldrich P6148) in PBS for 10 min, 
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permeabilised with 0.1% Triton X-100 (Sigma, T8787) in PBS for 10 min and blocked with 5% 
donkey or goat serum in 1% BSA-PBS containing 0.01% Tween 20 (Sigma-Aldrich; PBST). In 
some cases, required primary antibodies were of the same species as the antibodies used to 
functionalise beads, or as treatment. To block secondary antibody binding to these sites, cells were 
incubated with an excess of anti-mouse secondary antibody in 1% BSA-PBST for 1h followed by 
PBS washing prior to incubation with primary antibodies prepared in 1% BSA-PBST for 1 h at 
room temperature or overnight at 4°C. Cells were washed in PBST and incubated with donkey or 
goat Alexa Fluor conjugated secondary antibodies (1:1,000; Thermo Fisher Scientific) and 
phalloidin (1:40; Thermo-Fisher Scientific, or 1:1,000; Santa Cruz Biotechnology) in 1% BSA-
PBST for 30 min to 1 h at room temperature. Finally, coverslips were washed in PBST, and nuclei 
stained with 1 µg ml-1 DAPI (Sigma Aldrich) prior to mounting using ProLong mounting reagent or 
mounted in ProLong containing DAPI (Thermo Fisher Scientific, P36931). Primary antibodies: 
rabbit anti-syndecan-4 (1:100; Abcam ab24511; RRID:AB_448112), mouse anti-integrin β1, clone 
A-4 (1:100; Santa Cruz Biotechnology sc-374429; RRID:AB_11012020), mouse anti-integrin β1, 
clone 12G10 (1:100; Santa Cruz Biotechnology sc-59827; RRID:AB_782089), rabbit anti-talin-1 
(1:400; Abcam, ab71333; RRID:AB_2204002), mouse anti-kindlin-2, clone 3A3 (1:250; Merck 
MAB2617; RRID:AB_10631873), mouse anti-β1 integrins, active conformation, clone HUTS-4 
(1:100; Merck MAB2079Z; RRID:AB_2233964), mouse anti-YAP, clone 63.7 (1:200; Santa Cruz 
Biotechnology sc-101199; RRID:AB_1131430), rabbit anti-GFP (1:2,000; Abcam ab6556; 
RRID:AB_305564), mouse anti-HA.11 epitope tag, clone 16B12 (1:1,000; Biolegend 901513; 
RRID:AB_2565335), mouse anti-α-actinin, clone BM-75.2 (1:200; Sigma Aldrich A5044; 
RRID:AB_476737). 
 
Samples were imaged using epifluorescent microscopy (Leica DMI4000B, Leica DMi8, Nikon 
Eclipse Ti, AE31 Motic), total internal reflection fluorescence (TIRF) microscopy (Nikon Eclipse 
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Ti), confocal microscopy (Zeiss LSM 710, Nikon Eclipse Ti) or structured illumination microscopy 
(GE OMX) as indicated in figure legends. Image quantification was conducted using NIS Elements 
(Nikon) or Fiji (ImageJ, NIH)49. A region of interest (ROI) with inner diameter equal to the bead 
size and outer diameter 9 µm was used to quantify immunofluorescent staining or GFP intensity at 
the bead adhesion. In live GFP images, this was applied to a single epifluorescent image for each 
time point. For localisation of adhesion proteins to the bead in immunofluorescently stained cells, 
the location of the bead was first located in widefield mode, and then imaged using confocal 
microscopy with a z-spacing of 125 µm. Intensity within the ROI was summed through 5 z-sections 
expressed as mean fluorescent intensity. Focal adhesion size was assessed from TIRF microscopy 
images or confocal z-sections of the cell’s basal surface. An intensity-based threshold was applied 
to images to isolate talin-1, kindlin-2 or active integrin β1 enriched focal adhesions from 
background for selection. To assess YAP nuclear:cytoplasmic ratio, DAPI stained nuclei were 
selected based on an intensity threshold which provided ROIs for each nucleus. Morphological 
outlines of cell area were manually traced on F-actin images providing ROIs for each cell. The 
nucleus ROI could be subtracted from the cell ROI to obtain the cytoplasmic ROI. The mean 
intensity within each ROI was used to calculate the YAP nuclear:cytoplasmic ratio. 
 
RhoA activity assay 
Total RhoA and active RhoA-GTP were quantified using total RhoA ELISA and active RhoA G-
LISA assay kits (Cytoskeleton, Inc. BK150 and BK124) according to the manufacturer’s 
instructions. Immediately after treatment, cells were rinsed with ice-cold PBS and homogenised in 
ice-cold lysis buffer. Protein was quantified and sample concentration adjusted to 0.5 mg ml-1. For 
the G-LISA, binding buffer was added, and assays performed in triplicate using 1.5 µg protein per 
well. Target binding to the Rho GTP-binding protein coated well was facilitated by 30 min 
incubation at 4°C with shaking, followed by washing. For the ELISA, protein lysate was added to 
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wells coated with anti-Rho IgY antibody and incubated for 120 min at room temperature followed 
by washing. Antigen-presenting buffer was added for 2 min, removed, and samples incubated with 
the anti-RhoA antibody (1:250) for 45 min (G-LISA) or 1 h (ELISA) at room temperature. Samples 
were washed three times and incubated with HRP conjugated secondary antibody for 45 min or 1 h 
at room temperature. HRP detection reagent was added, samples incubated briefly, and absorbance 
measured at 490 nm. 
 
Gene expression analysis 
RNA was isolated using the RNeasy Mini Kit (Qiagen 74104). The High-Capacity RNA-to-cDNA 
Kit (Thermo Fisher Scientific 4387406) was used to reverse transcribe 1 µg of RNA. Real time RT-
PCR was performed in a 20 µl reaction with 100 ng cDNA, 300 nM primers and SYBR Green PCR 
Master Mix (Applied Biosystems 4309155). Primer sequences were: connective tissue growth 
factor (CTGF): forward 5’-CATACTCCACAGAATTTAGCTC-3’, reverse 5’-
TTAAGAAGGGCAAAAAGTGC-3’; ankyrin repeat domain 1 (ANKRD1): forward 5’-
TGAGTATAAACGGACAGCTC-3’, reverse 5’-TATCACGGAATTCGATCTGG-3’; and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH): forward 5’-ACAGTTGCCATGTAGACC-
3’, reverse 5’-TTTTTGGTTGAGCACAGG-3’. Relative expression was determined using the 
2−∆∆Ct method with GAPDH used as endogenous control. 
 
Molecular Dynamics (MD) and Steered Molecular Dynamics (SMD) simulations 
In simulations, we used the syndecan-4 structure including transmembrane and cytoplasmic 
domains. The NMR structure of the cytoplasmic domain (ID 1EJP in protein data bank) was used, 
while the transmembrane domain was modelled with SWISS-MODEL tool using the NMR 
structure of the dimeric transmembrane domain of human glycophorin A (ID 1AFO in protein data 
bank) as a template. A lipid membrane with 40 % of POPC (144 residues), 15 % POPS (54 
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residues), 5 % PIP2 (18 residues) and 40 % cholesterol (144 residues) was generated using 
Charmm-gui50. Embedding of protein into the membrane was performed by applying high lateral 
pressure on the system as described before51. All simulations were performed using Gromacs 
2016.1 (ref. 52) at the Sisu supercomputer, CSC, Finland. All-atom OPLS-AA force field53 and 
explicit TIP3P water model54 in 0.15 M KCl neutral solution were used. Energy minimisation of the 
system was performed in 10,000 steps using the steepest descent algorithm. Equilibration of the 
system was performed in three phases using harmonic position restraints on lipid/cholesterol heads 
in the Z dimension and on all heavy atoms of protein. (1) NVT ensemble simulation was performed 
for 100 ps utilising the Berendsen weak coupling algorithm55 at 100 K. (2) Next, the system was 
heated from 100 to 310 K with constant heating rate over 1 ns using an NPT ensemble at 1 bar, 
using the Berendsen algorithm to control both temperature and pressure. Semi-isotropic pressure 
coupling was used for all the simulations to control pressure in the XY plane (membrane plane) and 
in the Z dimension separately. Temperature coupling was applied separately for protein/membrane 
and solution parts. (3) The final equilibration phase was performed using NPT ensemble at 310 K 
and 1 bar using Nose-Hoover56,57 and Parrinello-Rahman58 algorithms, respectively. These 
conditions were used in all subsequent simulations. An integration time step of 2 fs was used in all 
the simulations. Equilibrium MD simulations (with no force applied) for 50 ns were conducted, 
considering the first 20 ns as a relaxation step. Hence, conformation of the system at 20 ns of the 
first run of equilibrium MD simulation was used as a starting structure for SMD simulations. The 
pulling vector was set between the membrane (centre of mass) and Cα of N-terminal residues of the 
protein. SMD simulations were performed with constant force pulling using different force regimes: 
25 pN, 50 pN, 100 pN and 200 pN. Two simulations were conducted for 25 pN, 100 pN and 200 
pN, and four simulations for equilibrium MD and SMD with 50 pN of constant force pulling. All 
the simulations were run for 50 ns, except SMD simulations with 25 pN which were run for 100 ns. 
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Statistical analysis 
Statistical analyses were conducted using GraphPad Prism 8 (RRID:SCR_002798; GraphPad Inc.) 
or Minitab 18 (RRID:SCR_014483; Minitab Inc.). Data were generated from multiple experimental 
repeats each containing multiple biological and technical replicates. Details of data presentation, 
number of replicates, statistical tests and significance is denoted in the figure legends. Where 
datasets followed a parametric distribution, experimental groups were compared using two-sided 
two-sample or paired t-tests, or when multiple experimental variables, analysis of variance with 
Tukey pairwise comparisons. Where datasets were non-parametric, two-sided Mann-Whitney tests, 
or two-sided paired rank tests were used in place of two-sample and paired t-tests respectively. In 
the case of multiple experimental groups, non-parametric data was transformed to fit a parametric 
distribution using a Box-Cox transformation prior to analysis of variance and pairwise comparisons, 
or the Kruskal-Wallis test used. Non-parametric bead displacement data over successive force 
pulses was analysed using the Friedman test with Dunn pairwise comparisons. The significance 
level for all tests was set at 0.05. 
 
Data availability 
The data that support the findings of this study are available from the corresponding authors upon 
reasonable request. 
 
Code Availability 
MATLAB code used to track bead displacements in magnetic tweezers experiments is available 
from A.D.R.H. upon reasonable request. Code used in molecular dynamics simulations is available 
from V.P.H. upon reasonable request. 
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Figure legends 
Figure 1. Tension on syndecan-4 induces Rho-dependent adaptive stiffening mediated by 
EGFR and PI3K. a, Schematic representation of electromagnetic tweezers pulling on a ligand-
coated magnetic bead bound to the apical cell surface. Inset depicts an anti-syndecan-4 antibody-
coated bead binding to the extracellular domain of syndecan-4. b, Representative cell stiffening 
response apparent as a progressively diminishing bead displacement over 12 force pulses. Bead 
displacement at force pulse 1 and 12 is indicated. n = 32 cells. c, Relative displacement of beads 
bound to pancreatic stellate cells (PSCs) plated on fibronectin. Beads were functionalised with anti-
syndecan-4 antibody (Anti-Sdc4; n = 32), the heparin binding domain fragment of fibronectin (FN-
HBD; n = 31), poly-L-lysine (PLL; n = 20) or anti-transferrin receptor protein-1 antibody (Anti-
TfR1; n = 36 cells). Displacement for all pulses was normalised to the average displacement of 
force pulse 1. Friedman test with Dunn pairwise comparisons: *P ≤ 0.0116, **P ≤ 0.0041, ***P < 
0.0001 vs force pulse 1. d, Relative syndecan-4 bound bead displacement at force pulse 1 and 12 in 
control PSCs (n = 32), or PSCs treated with latrunculin A (Lat A; n = 20), C3 transferase (C3; n = 
20), Y-27632 (Y-27; n = 20), LY-294002 (LY-29; n = 20), or SH-5 (n = 24 cells). See 
Supplementary Fig. 4 for single cell data. Two-sided paired signed rank test: **P = 0.002, ***P < 
0.0001. Mean ± s.e.m. e,f, Syndecan-4 bound beads on cells expressing the PIP3 biosensor PH-
AKT-GFP were exposed to sustained tension of 1 nN for 60 s in untreated conditions (e) or in the 
presence of an epidermal growth factor (EGF) neutralising antibody (f). Representative confocal 
slice images of the area surrounding the bead pre (0 s) and post (60 s) force application. Mean PH-
AKT-GFP fluorescent intensity, in a region of interest depicted by white dashed overlay, is 
presented relative to intensity prior to force application. See Supplementary Fig. 6 for control GFP 
data. Scale bar: 5 µm. n(e) = 24, n(f) = 10 cells. Two-sided paired signed rank test: ***P = 0.0002, 
n.s. P = 0.723. Boxes represent median and interquartile range, whiskers extend to the max/min 
data points, individual values overlaid. 
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Figure 2. Tension on syndecan-4 leads to PI3K dependent cell-wide growth of focal adhesions. 
a, Syndecan-4 bound beads on pancreatic stellate cells plated on fibronectin and pre-treated with 
vehicle (DMSO) or PI3K inhibitor LY-294002 were exposed to sustained tension of ~200 pN for 5 
min using a permanent magnet. b, Representative confocal maximum projection images of talin-1 
and kindlin-2 at the bead site. White dashed overlay depicts region of interest (ROI) surrounding 
bead used for intensity quantification. Scale bar 5 µm. c, Mean fluorescent intensity of talin-1 and 
kindlin-2 in a ROI surrounding the bead was summed from each confocal section and presented 
relative to each unstimulated control. nTalin-1 = 8-12 cells (nVehicle-Control = 12, nVehicle-Force = 11, nLY-
294002-Control = 9, nLY-294002-Force = 8), nKindlin-2 = 8-18 cells (nVehicle-Control = 14, nVehicle-Force = 18, nLY-
294002-Control = 8, nLY-294002-Force = 8); two-sided two-sample t-test: **P = 0.0021, ***P = 0.0001, n.s. 
P ≥ 0.543. Mean ± s.e.m. d, Representative TIRF microscopy images of talin-1 and kindlin-2 
enriched basal focal adhesions. Scale bar 5 µm, inset scale bar 1 µm. e, Mean area of talin-1 and 
kindlin-2 positive focal adhesions. nTalin-1 = 10-16 cells (nVehicle-Control = 15, nVehicle-Force = 15, nLY-
294002-Control = 10, nLY-294002-Force = 16) and nKindlin-2 = 12 cells with ≥ 5 focal adhesions measured per 
cell; general linear model for analysis of variance with Tukey pairwise comparisons: ***P < 
0.0001, n.s. P ≥ 0.9726. Boxes represent median and interquartile range, whiskers extend to the 
max/min data points, individual values overlaid. 
 
Figure 3. Tension on syndecan-4 triggers cell-wide integrin activation via PIP3 binding to 
kindlin-2. a, Representative TIRF microscopy images of active β1 integrins in the basal plane of 
pancreatic stellate cells in (i) unstimulated control conditions, (ii) in response to a sustained tension 
force of ~200 pN for 5 min applied to syndecan-4, (iii) with 1 mM MnCl2 treatment for 30 min 
(Mn2+), and (iv) with 2 mM EDTA treatment for 30 min, both (iii and iv) in the absence of force 
application. b, Mean active integrin β1 focal adhesion (FA) area. nControl = 14, nForce = 14, nMn2+ = 
46, nEDTA = 86 cells. c, Representative TIRF microscopy images of active β1 integrins in response 
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to sustained tension on syndecan-4 in cells treated with siRNA targeting kindlin-2 (siKindlin-2), re-
expressing a kindlin-2 mutant (K390A) which lacks phosphoinositide binding activity (siKindlin-2 
+ Kindlin-2 K390A), and re-expressing wild type (WT) kindlin-2. Scale bar 10 µm, inset scale bar 2 
µm. d, Mean active integrin β1 focal adhesion (FA) area. nsiKindlin-2 = 14, nsiKindlin-2 + Kindlin-2 K390A = 
14, nsiKindlin-2 + Kindlin-2 WT - Control = 196, nsiKindlin-2 + Kindlin-2 WT - Force = 52 cells with ≥ 5 focal adhesions 
measured per cell; two-sided Mann-Whitney test: *P = 0.024, ***P ≤ 0.0002, n.s. P ≥ 0.73. Boxes 
represent median and interquartile range, whiskers extend to the max/min data points. 
Figure 4. Tension on syndecan-4 activates RhoA via integrin ligation and regulates YAP 
activity. a, Pancreatic stellate cells (PSCs) on fibronectin were subjected to sustained tension of 
~200 pN on syndecan-4 for 5-15 min, with total and active RhoA presented relative to unstimulated 
control. nControl/5min/15min = 9, n10min = 6 biologically independent samples; Kruskal-Wallis test with 
Dunn pairwise comparisons: *P = 0.0104, ***P < 0.0001, n.s. P = 0.823. b, Relative syndecan-4 
bound bead displacement in untreated control conditions (n = 32), with IgG1-κ isotype control 
antibody (n = 15), or with anti-fibronectin antibody (clone 3E3) which blocks the RGD binding site 
on fibronectin (Anti-FN 3E3 Ab, n = 22 cells). See Supplementary Fig. 10 for single cell data. Two-
sided paired signed rank test: *P = 0.035, ***P < 0.0001, n.s. P = 0.134. c, Representative confocal 
microscopy sections at the cell’s basal surface for active β1 integrin and F-actin in response to 
sustained ~200 pN tension on syndecan-4 in cells treated with IgG1-κ isotype control antibody, or 
Anti-FN 3E3 Ab. Scale bar 20 µm, inset scale bar 5 µm. d, Mean active integrin β1 focal adhesion 
(FA) area. 13-36 cells were analysed with nIgG1-κ-Control = 274, nIgG1-κ-5min = 407, nAnti-FN-Control = 417, 
nAnti-FN-5min = 203 adhesions; two-sided Mann-Whitney test: ***P = 0.001, n.s. P = 0.581. e, Total 
and active RhoA relative to unstimulated control for cells subjected to sustained syndecan-4 tension 
for 5-15 min in the presence of IgG1-κ and Anti-FN 3E3 antibodies. n = 6 biologically independent 
samples; general linear model for analysis of variance with Tukey pairwise comparisons: ***P = 
36 
0.0006, *P = 0.0488, n.s. P ≥ 0.063. f, Representative phase contrast and wide field images for 
DNA, GFP, F-actin, and YAP in wild type (WT) and syndecan-4 null (Sdc4-/-) mouse embryonic 
fibroblasts on fibronectin. Scale bar 10 µm. g, Mean nuclear:cytoplasmic YAP intensity. nWT = 43, 
nSdc4-/- = 64, nSdc4-/-+WT-Sdc4-GFP = 21 cells; general linear model for analysis of variance with Tukey 
pairwise comparisons: ***P < 0.001. h, Relative mRNA expression of YAP target genes 
connective tissue growth factor (Ctgf) and ankyrin repeat domain-1 (Ankrd1). nWT = 5, nSdc4-/- = 6 
biologically independent samples; two-sided two-sample t-test: *P = 0.011, **P = 0.001. Boxes 
represent median and interquartile range, whiskers extend to the max/min data points; bar charts 
represent mean ± s.e.m.; individual values overlaid (a, e, h). 
Figure 5. Syndecan-4 mechanotransduction requires the V-region which changes 
conformation under force. a, Schematic representation of syndecan-4 structure. b, Cytoplasmic 
domain amino acid sequences for wild type syndecan-4 (Sdc4WT), syndecan-4 which cannot be 
phosphorylated on Y180 (Sdc4Y180L), phospho-mimetic syndecan-4 (Sdc4Y180E), syndecan-4 
truncated in the C2 domain (Sdc4∆195E) and syndecan-4 truncated in the V domain (Sdc4∆187I). 
c, Displacement of syndecan-4 bound beads in response to pulsatile 1 nN force in mouse embryonic 
fibroblast cell lines expressing wild type or mutant syndecan-4 on fibronectin, relative to force 
pulse 1. See Supplementary Fig. 15 for single cell data. nSdc4WT = 27, nSdc4Y180L = 35, nSdc4Y180E = 43, 
nSdc4∆195E = 23, nSdc4∆187I = 22 cells; Friedman test with Dunn pairwise comparisons: *P ≤ 0.0238, 
**P ≤ 0.0092, ***P ≤ 0.001 vs force pulse 1. Mean ± s.e.m. d, Molecular structure snapshots of 
syndecan-4 at 5 ns intervals during a 50 ns simulation with no force applied (molecular dynamics 
(MD)) and with constant force pulling at 50 pN on the extracellular domain of syndecan-4 (steered 
molecular dynamics (SMD)). e-f, Root mean square fluctuation (RMSF) of syndecan-4 Cα atoms 
overlaid on molecular structure (e) and plotted against residue (f). g, Average position of lysine 
K190 Cα atoms on the membrane plane representing directed movement of the cytoplasmic domain 
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from the virtual axis (located between transmembrane helices) towards the membrane in SMD. 
Average position was calculated for both K190 Cα atoms (chain A and B) in each 5 ns increment. 
See Supplementary Fig. 17 for amino acid sequence used in simulations. 
 
Figure 6. Tension stabilises a syndecan-4/α-actinin/F-actin linkage to facilitate adaptive 
stiffening. a, Schematic representation of the interaction between syndecan-4 and α-actinin which 
provides a mechanical link to the cytoskeleton. α-actinin spectrin repeat 4 (SR4) binds to the 
syndecan-4 variable (V) domain, while the calponin-homology (CH) domains of α-actinin bind to 
F-actin. b, Representative wide field microscopy images of α-actinin-1 (ACTN1)-GFP expressing 
mouse embryonic fibroblasts (MEFs) pre (0 s) and post (60 s) the application of sustained tension 
on syndecan-4. MEFs were depleted of endogenous α-actinin-1 and α-actinin-4 (siActn1Actn4) and 
transfected to express ACTN1-GFP. Imaging conducted in the apical focal plane of the bead 
attachment. Scale bar: 20 µm. See Supplementary Fig. 20 for GFP control. c, Mean ACTN1-GFP 
intensity, in a region of interest surrounding the bead depicted by yellow dashed overlay, relative to 
mean intensity prior to force application. n = 10 cells; two-sided paired signed rank test: **P = 
0.002. Boxes represent median and interquartile range, whiskers extend to the max/min data points, 
individual values are overlaid. d, Relative syndecan-4 bound bead displacement in MEFs treated 
with non-targeting control siRNA (siNT; n = 18) or siRNAs targeting Actn1 and Actn4 
(siActn1Actn4; n = 18) with expression of ACTN1-GFP (siActn1Actn4 + ACTN1-GFP; n = 23) or a 
mutant form of α-actinin with the actin binding domain (ABD) deleted (siActn1Actn4 + ACTN1-
∆ABD-GFP; n = 20 cells). See Supplementary Fig. 21 for single cell data. Friedman test with Dunn 
pairwise comparisons: *P ≤ 0.0492, **P ≤ 0.0058, ***P ≤ 0.0009 vs force pulse 1. Mean ± s.e.m. e, 
Schematic representation of the described mechanotransduction pathway where force on syndecan-
4 (1) activates PI3K (2) in an EGFR-dependent manner. PIP3 binds kindlin-2 leading to integrin 
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activation (3) and ligation of integrins with ECM which instigates RhoA signalling (4) leading to 
adaptive cell stiffening (5) with the potential to modulate matrix remodelling (6). 
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Supplementary Figures 
 
Supplementary Figure 1: Specificity of functionalised bead binding to syndecan-4. a,b, 
Immunofluorescent staining for (a) syndecan-4 (Sdc4) and (b) integrin β1 with f-actin and DNA as 
indicated. Representative basal and apical confocal z-sections are presented with higher 
magnification insets of the bead attachment region at a z-section spacing of 0.366 µm. To assess 
the specificity of cell binding to functionalised beads, pancreatic stellate cells were plated on 
fibronectin coated coverslips and beads allowed to attach for 30 min. Beads were functionalised 
with mouse anti-syndecan-4 (Anti-Sdc4) ectodomain antibody, the heparin binding domain 
fragment of fibronectin (FN-HBD), unmodified fibronectin (FN), and mouse anti-transferrin receptor 
protein-1 (Anti-TfR1). Unbound beads were removed with a PBS wash. A permanent magnet was 
used to apply a sustained force of approx. 200 pN to cell-bound beads for 5 min. Cells were fixed 
immediately post force application, and immunofluorescently stained followed by confocal imaging 
of bead attachment sites. Note the presence of intense syndecan-4 (red) staining in the bead 
attachment region in beads functionalised with anti-Sdc4, FN-HBD and FN, and the absence of 
this in anti-TfR1 beads in (a). Similarly note the absence of integrin β1 (green) surrounding beads 
in control (unstimulated) anti-Sdc4, FN-HBD and Anti-TfR1 beads in (b). Force led to accumulation 
of Sdc4 and/or integrin β1 at the bead site for anti-Sdc4, FN-HBD and FN beads, while no increase 
was evident for anti-TfR1 beads which do not elicit a mechanoresponse. Experiments were 
repeated independently twice with consistent results. Full field scale bar 10 µm; inset scale bar 2.5 
µm. 
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Supplementary Figure 2: Western blot confirming syndecan-4 (Sdc4) binding to 
functionalised cell-bound beads. Syndecan-4 is present in the adhesion complex with 
fibronectin (FN), 40K Heparin binding domain of fibronectin (FN-HBD), and anti-syndecan-4 
antibody (Anti-Sdc4) coated beads. Functionalised beads were allowed attach to pancreatic 
stellate cells for 30 min before cell lysis and magnetic isolation of the bead bound adhesion 
complex. Representative blot from three independent experiments with similar results. 
 
 
 
 
Supplementary Figure 3: Tension on syndecan-4 increases cellular stiffness. To examine the 
cell stiffness in response to an applied force, the time-dependent compliance (J(t)) of the cell was 
calculated from the time-dependent bead displacement (x(t)) using J(t)=6πax(t)/F(t), where a is the 
bead radius. The viscoelastic response of the cell was characterized by fitting the creep 
compliance during force application to a modified Kelvin-Voigt model used to describe viscoelastic 
materials. a, Schematic representation of the modified Kelvin-Voigt model comprising a spring and 
dashpot in parallel, with a dashpot in series. b, Representative bead displacement curve for first 
force pulse. c, Representative bead displacement curve transformed into compliance and fitted to 
the modified Kelvin-Voigt model. d, Comparison of cell stiffness denoted by the spring constant k 
during the first and last 1 nN force pulse. Representative cell stiffness matches data presented in 
Figure 1b from n = 32 cells. 
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Supplementary Figure 4: Single cell data corresponding to summarised magnetic tweezers 
bead displacement data presented in Figure 1. Magnetic bead displacement amplitude in 
response to a 1 nN pulsatile force is presented for each pancreatic stellate cell (PSC) relative to 
the average first pulse displacement. a-d, Beads were functionalised with (a) mouse anti-
syndecan-4 ectodomain antibody (Anti-Sdc4; n = 32), (b) the heparin binding domain fragment of 
fibronectin (FN-HBD; n = 31), (c) poly-L-lysine (PLL; n = 20), and (d) mouse anti-transferrin 
receptor protein-1 (Anti-TfR1; n = 36 cells). Friedman test with Dunn pairwise comparisons: *P ≤ 
0.0116, **P ≤ 0.0041, ***P < 0.0001 vs force pulse 1. e, Single cell data for relative magnetic bead 
displacement at force pulse 1 and 12 for Anti-Sdc4 magnetic beads bound to untreated control 
PSCs (n = 32) or PSCs treated with F-actin polymerisation inhibitor latrunculin A (Lat A; 0.5 µM, 1 
h; n = 20), Rho inhibitor C3 transferase (C3; 2 µg/mL, 4 h; n = 20), Rho-associated protein kinase 
(ROCK) inhibitor Y-27632 (10 µM, 1 h, n = 20), phosphoinositide 3-kinase (PI3K) inhibitor LY-
294002 (30 µM, 1 h; n = 20), or AKT inhibitor SH-5 (10 µM, 1 h; n = 24 cells). Two-sided paired 
signed rank test: **P = 0.002, ***P < 0.0001. Grey dots represent individual bead displacements, 
mean and s.e.m. overlaid. 
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Supplementary Figure 5: Force applied to syndecan heparan sulphate chains induces 
adaptive cell stiffening. a,b, Magnetic bead displacement amplitude in response to a 1 nN 
pulsatile force is presented as summarised mean value (a) and for each pancreatic stellate cell (b) 
relative to the average first pulse displacement. Beads were functionalised with fibronectin treated 
with an RGD integrin binding site blocking antibody (clone 3E3) which leaves the heparin binding 
domain available (FN + Anti-FN 3E3 Ab; n = 19 cells). Friedman test with Dunn pairwise 
comparisons: *P = 0.0104, **P = 0.0054 vs force pulse 1. Mean ± s.e.m. with individual values 
overlaid. 
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Supplementary Figure 6: Confirmation of specificity of force induced PI3K activation to 
syndecan-4. a, Sustained force applied to syndecan-4 bound beads on pancreatic stellate cells 
expressing an empty control GFP vector did not lead to GFP accumulation in the bead region, 
unlike in cells expressing the PIP3 biosensor PH-AKT-GFP (Fig. 1e). b, Sustained force applied to 
poly-L-lysine (PLL) coated beads attached to cells expressing PH-AKT-GFP did not lead to PH-
AKT-GFP accumulation at the bead; indicating that force-induced PI3K activation is specific to 
syndecan-4. Cells expressing either vector were exposed to a sustained tensional force of 1 nN for 
60 s. Representative images of the area surrounding the magnetic bead pre (0 s) and post (60 s) 
force application. Mean PH-AKT-GFP fluorescent intensity, in a region of interest surrounding the 
bead depicted by white dashed overlay, is presented relative to mean intensity prior to force 
application. Scale bar: 5 m. n = 10 cells from 2 biologically independent experiments; two-sided 
paired signed rank test: (a) n.s. P = 0.655, (b) n.s. P = 0.987. Boxes represent median and 
interquartile range, whiskers extend to the max/min data points, individual values are overlaid. 
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Supplementary Figure 7: EGFR is required for syndecan-4 mediated adaptive cell stiffening. 
Pulsatile force applied to syndecan-4 bound beads in the presence of a,b, Epidermal growth factor 
receptor (EGFR) inhibitor Gefitinib (Santa Cruz Biotechnology sc-202166, 15 µM, 2h; n = 16 cells) 
or c,d, anti-epidermal growth factor (EGF) neutralising antibody (R&D Systems MAB236, 5 µg ml-1, 
30 min; n = 17 cells) did not induce an adaptive stiffening response. Magnetic bead displacement 
amplitude in response to a 1 nN pulsatile force is presented as mean (a,c) and for each pancreatic 
stellate cell (b,d) relative to the average first pulse displacement. Beads were functionalised with 
mouse anti-syndecan-4 ectodomain antibody. Mean ± s.e.m. with individual values overlaid. 
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Supplementary Figure 8: Total integrin 1 incorporation into focal adhesions does not 
change in response to tension on syndecan-4. a, Representative epifluorescent microscopy 
images of total integrin 1 at the basal surface of pancreatic stellate cells in control conditions or in 
response to a sustained tensional force of approx. 200 pN for 5 min applied using a permanent 
magnet. Cells were fixed immediately post force application and immunofluorescently stained for 
integrin 1. Scale bar 5 m. b, Quantification of mean focal adhesion size for integrin 1 containing 
adhesions. The mean adhesion size from > 10 focal adhesions from 3 regions of interest per cell 
are presented. nControl = 10 cells, nForce = 9 cells; two-sided two-sample t-test: n.s. P = 0.678. Boxes 
represent median and interquartile range, whiskers extend to the max/min data points, with mean 
cell values overlaid. 
 
 
 
 
Supplementary Figure 9: Immunofluorescent staining demonstrating knockdown and re-
expression of kindlin-2. Representative epifluorescent microscopy images of kindlin-2 at the 
basal surface of pancreatic stellate cells. Cells were left untreated (Control), treated with siRNA 
targeting kindlin-2 (siKindlin-2), and subsequently transfected with a plasmid to re-express a 
kindlin-2 mutant (K390A) lacking phosphoinositide binding activity (siKindlin-2 + Kindlin-2 K390A). 
Cells were fixed and immunofluorescently stained for kindlin-2. White arrowheads indicate 
incorporation of kindlin-2 in focal adhesions with no kindlin-2 positive adhesions observed in the 
siKindlin-2 condition. Representative images from 2 independent repeat experiments. Scale bar 5 
m. 
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Supplementary Figure 10: Single cell data corresponding to summarised magnetic tweezers 
bead displacement data presented in Figure 4b. Bead displacement presented relative to the 
mean value for force pulse 1. Pulsatile force applied to syndecan-4 bound beads on pancreatic 
stellate cells plated on fibronectin in untreated control conditions (n = 32), in the presence of 
isotype control mouse IgG1-κ antibody (clone MOPC-21, Merck MABF1081Z; n = 15), and in the 
presence of mouse anti-fibronectin antibody (clone 3E3, Merck MAB88916-C), which blocks the 
RGD integrin binding site of fibronectin preventing new integrin-RGD connections (n = 22 cells). 
Both antibodies were added at 20 µg ml-1 for 30 min prior to initiation of magnetic tweezer 
stimulation and were maintained throughout experiments. Two-sided paired signed rank test: *P = 
0.035, ***P < 0.0001, n.s. P = 0.134. Mean ± s.e.m. with individual values overlaid. 
 
 
 
Supplementary Figure 11: Blocking of fibronectin’s RGD binding site does not alter cell 
spread area. a, Representative epifluorescent microscopy images of f-actin in pancreatic stellate 
cells in the presence of isotype control mouse IgG1-κ antibody (clone MOPC-21, Merck 
MABF1081Z) or mouse anti-fibronectin antibody (clone 3E3, Merck MAB88916-C), which blocks 
the RGD integrin binding site of fibronectin preventing new integrin-RGD connections. Both 
antibodies were added at 20 µg ml-1 for 30 min prior to fixation of cells. Scale bar 100 µm. b, 
Quantification of cell spread area corresponding to images in (a). Morphological outlines were 
manually traced on F-actin overlays in ImageJ. nIgG1-κ = 142 cells, nAnti-FN 3E3 = 91 cells; two-sided 
Mann-Whitney test: P = 0.416. Boxes represent median and interquartile range, whiskers extend to 
the max/min data points. 
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Supplementary Figure 12: Syndecan-4 tension mediated cell stiffening and RhoA activation 
persists in cells seeded on collagen type I. a,b, 1 nN pulsatile force was applied to syndecan-4 
bound beads on pancreatic stellate cells (PSCs) plated on collagen type I. Mean (a) and individual 
cell (b) bead displacement presented relative to the average displacement of force pulse 1. n = 27 
cells; Friedman test with Dunn pairwise comparisons: *P = 0.0179, ***P = 0.0007 vs force pulse 1. 
c, Relative syndecan-4 bound bead displacement for PSCs plated on fibronectin (n = 32, see 
Supplementary Fig. 3) and on collagen as presented in (a,b). The reduction in bead displacement 
with each force pulse is less rapid in cells on collagen compared to cells on fibronectin. nFibronectin = 
32, nCollagen type I = 27 cells; two-sided two sample t-test: *P = 0.046. d, Syndecan-4 bound beads on 
PSCs plated on collagen type I were subjected to sustained tension of ~200 pN for 15 min, with 
total and active RhoA assessed using ELISA and G-LISA respectively, presented relative to 
unstimulated control. The application of sustained force led to an increase in RhoA activation, but 
this was less marked as that in cells on fibronectin (Fig. 4a). n = 9 biologically independent 
samples; two-sided two-sample t-test: *P = 0.037. Mean ± s.e.m. with individual values overlaid. 
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Supplementary Figure 13. Syndecan-4 is required for YAP nuclear localisation on 
fibronectin coated 25 kPa gels. a, Wild type (WT) and syndecan-4 null (Sdc4-/-) mouse 
embryonic fibroblasts were plated onto fibronectin coated 25 kPa polyacrylamide gels, fixed and 
immunofluorescently stained for YAP. Representative wide field microscopy images for DNA, F-
actin and YAP. Scale bar 20 µm. b, Quantification of mean nuclear:cytoplasmic YAP intensity. nWT 
= 18, nSdc4-/- = 16 cells; two-sided two-sample t-test: ***P < 0.0001. Boxes represent median and 
interquartile range, whiskers extend to the max/min data points. 
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Supplementary Figure 14: Syndecan-4 is required for YAP nuclear translocation in mouse 
embryonic fibroblasts plated on fibronectin or collagen type I. Wild type (WT) and syndecan-4 
null (Sdc4-/-) mouse embryonic fibroblasts were plated on fibronectin or collagen type I coated 
substrates. a, Representative epifluorescent microscopy images for DNA, F-actin, YAP and 
merged channels. Scale bar 20 m. b, Quantification of mean nuclear:cytoplasmic YAP intensity. 
nFibronectin-WT = 96, nFibronectin-Sdc4-/- = 82, nCollagen 1-WT = 91, nCollagen 1-Sdc4-/- = 172 cells; two-sided Mann-
Whitney tests: **P = 0.005, ***P < 0.001. Boxes represent median and interquartile range, 
whiskers extend to the max/min data points. YAP downregulation in Sdc4-/- cells was not affected 
by substrate ECM with Sdc4-/- cells on collagen type I exhibiting a reduction in nuclear YAP 
compared to WT. Both WT and Sdc4-/- cells exhibited decreased nuclear:cytoplasmic YAP on 
collagen type I compared to fibronectin. 
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Supplementary Figure 15: Single cell data corresponding to summarised magnetic tweezers 
bead displacement data presented in Figure 5c. a-e, Bead displacement presented relative to 
the mean value for force pulse 1 in response to 1 nN pulsatile force applied to syndecan-4 bound 
beads on mouse embryonic fibroblasts (MEFs) plated on fibronectin. MEF cell lines expressing (a) 
wild type syndecan-4 (Sdc4WT; n = 27), (b) phospho-null syndecan-4 (Sdc4Y180L; n = 35), (c) 
phospho-mimetic syndecan-4 (Sdc4Y180E; n = 43), (d) syndecan-4 truncated in the C2 domain 
(Sdc4∆195E; n = 23), or (e) syndecan-4 truncated in the variable (V) domain (Sdc4∆187I; n = 22 
cells). Friedman test with Dunn pairwise comparisons: *P ≤ 0.0238, **P ≤ 0.0092, ***P ≤ 0.001 vs 
force pulse 1. Mean ± s.e.m. with individual values overlaid. 
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Supplementary Figure 16: Confirmation of syndecan-4 plasmid transfection into syndecan-4 
null (Sdc4-/-) mouse embryonic fibroblast (MEF) line. Representative epifluorescent 
microscopy images of immunofluorescent staining for F-actin and HA tagged syndecan-4 plasmid 
expression. Sdc4-/- MEFs expressing wild type syndecan-4 (Sdc4WT), syndecan-4 truncated in 
the C2 domain (Sdc4∆195E), or syndecan-4 truncated in the variable domain (Sdc4∆187I) were 
fixed 24 h post transfection. Images are representative from 2 biologically independent 
experiments with similar results. Scale bar 100 µm. 
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Supplementary Figure 17: Steered molecular dynamics (SMD) simulations reveal 
conformational changes in the cytoplasmic domain of syndecan-4 in response to force on 
the extracellular domain. a, Syndecan-4 amino acid sequence, where 1-18: signal peptide, 19-
145: extracellular domain (green), 146-170: transmembrane domain (brown), 171-198: cytoplasmic 
domain (purple). Region used in molecular dynamics (MD) and steered molecular dynamics (SMD) 
simulations is underlined. b, Multiple replica SMD simulations at 50 pN. Conformational changes of 
the cytoplasmic domain of syndecan-4 (upper panel) and sliding of syndecan-4 through the 
membrane (lower panel) in steered molecular dynamics (SMD) simulations using constant force 
pulling at 50 pN for 50 ns (4 parallel simulations). 
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Supplementary Figure 18: Effect of force magnitude on syndecan-4 conformation in 
molecular dynamics (MD) and steered molecular dynamics (SMD) simulations. 
Conformational changes of cytoplasmic domain of syndecan-4 (upper panel) and sliding of 
syndecan-4 through the membrane (lower panel) in MD over 50 ns (No force; 4 parallel 
simulations) and SMD simulations using constant force pulling at 25 pN for 100 ns (2 parallel 
simulations), 100 pN for 50 ns (2 parallel simulations) and 200 pN for 50 ns (2 parallel simulations). 
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Supplementary Figure 19: α-actinin-1-GFP localises to focal adhesions akin to endogenous 
α-actinin. a, Western blot demonstrating successful siRNA mediated knockdown of α-actinin-4. 
Mouse embryonic fibroblasts (MEFs) were untreated, treated with transfection reagent 
lipofectamine 3000 alone, with a non-targeting control siRNA (siNT), and siRNAs targeting both α-
actinin-1 (Actn1) and α-actinin-4 (Actn4; siActn1Actn4). Duplicate samples presented are 
representative from 2 biologically independent experiments with similar results. b, Representative 
maximum projection of a 3D super resolution structured illumination microscopy image of α-actinin-
1-GFP (ACTN1-GFP) localisation in Actn1 and Actn4 depleted MEFs. Note intense localisation to 
focal adhesions. Image representative of 3 biologically independent experiments with similar 
results. Scale bar 10 µm. c, Representative wide field immunofluorescent images of DNA, F-actin 
and α-actinin in pancreatic stellate cells under control unstimulated conditions, and in response to 
sustained 200 pN force for 5 min applied using a permanent magnet to syndecan-4 bound beads. 
Images were taken at the basal and apical (bead) plane. Note the localisation of α-actinin around 
the bead adhesion. Images representative of 2 independent experiments with similar results. Scale 
bar 20 µm. 
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Supplementary Figure 20: Force on syndecan-4 bound beads does not induce control 
empty vector GFP accumulation in the bead region. Sustained force of 1 nN for 60 s applied to 
syndecan-4 bound beads on mouse embryonic fibroblasts expressing an empty control GFP vector 
did not lead to GFP accumulation in the bead region, unlike in cells expressing -actinin-1 
(ACTN1)-GFP (Fig. 6b). Representative images of the area surrounding the magnetic bead pre (0 
s) and post (60 s) force application. Mean GFP fluorescent intensity, in a region of interest
surrounding the bead depicted by white dashed overlay, is presented relative to mean intensity 
prior to force application. Scale bar: 10 m. n = 10 cells; two-sided paired signed rank test: n.s. P = 
0.754. Boxes represent median and interquartile range, whiskers extend to the max/min data 
points, individual values are overlaid. 
Supplementary Figure 21: Single cell data corresponding to summarised magnetic tweezers 
bead displacement data presented in Figure 6d. a-d, Bead displacement presented relative to 
the mean value for force pulse 1 in response to 1 nN pulsatile force applied to syndecan-4 bound 
beads on mouse embryonic fibroblasts (MEFs) plated on fibronectin. MEFs were treated with (a) 
non-targeting control siRNA (siNT; n = 18) or (b) siRNAs targeting -actinin-1 (Actn1) and -
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actinin-4 (Actn4; siActn1Actn4; n = 18) with expression of (c) α-actinin-1 (ACTN1)-GFP 
(siActn1Actn4 + ACTN1-GFP; n = 23) or (d) a mutant form of α-actinin with the actin binding 
domain (ABD) deleted (siActn1Actn4 + ACTN1-∆ABD-GFP; n = 20 cells).; Friedman test with Dunn 
pairwise comparisons: *P ≤ 0.0492, **P ≤ 0.0058, ***P ≤ 0.0009 vs force pulse 1. Mean ± s.e.m. 
with individual values overlaid. 
 
 
 
Supplementary Figure 22: Syndecan-4 is expressed in wild type (WT) mouse embryonic 
fibroblasts (MEFs) and pancreatic stellate cells (PSCs) but not in syndecan-4 null (Sdc4-/-) 
MEFs. Western blot bands for syndecan-4 (Sdc4) and Ponceau-S staining for total protein. Blot 
representative of 3 independent experimental repeats with similar results. Full syndecan-4 blot is 
presented in Supplementary Fig. 23.  
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Supplementary Discussion 
Cell-wide integrin activation is triggered by PI3K and leads to subsequent production of freely diffusible PIP3 
phosphoinositides that bind to the PH domain of focal adhesion protein kindlin-2, switching β1 integrins into 
a high affinity state to promote ECM ligation. The diffusion rate of PIP3 is ~0.1-1 µm2s-1 (ref. 1), which is 
sufficient for the propagation of the biochemical signal to sites distal from that of force application to initiate 
global activation of integrins within the timescales of our experiments. It is therefore likely that the stiffening 
response to syndecan-4 mechanosensing represents a global cytoskeletal response rather than a local 
strengthening of the bead adhesion complex. 
Molecular dynamics simulations of tension application to the extracellular domain of syndecan-4 
revealed a force-dependent repositioning of the cytoplasmic domain where the V-region moved toward the 
plasma membrane. This mechanism contrasts with mechanotransduction mechanisms requiring mechanical 
unfolding of proteins to expose cryptic sites for signalling2. This conformation change may facilitate 
interaction between the V-region and membrane associated PIP2 which is necessary for PKC-α activation3, or 
facilitate α-actinin binding4. A direct interaction between the syndecan-4 V-region and α-actinin is a key 
functional unit that promotes the assembly of focal adhesions and their associated linear microfilament 
bundles5. We have found that force-induced stabilisation of a syndecan-4/α-actinin/F-actin molecular scaffold 
at the focal adhesion serves as a direct structural link to the cytoskeleton necessary for force transmission and 
downstream mechanosignalling. α-actinin also associates with integrins, vinculin and zyxin within focal 
adhesions. It may also possess signalling roles as reports indicate α-actinin interacts with PIP2 and focal 
adhesion kinase (FAK)6. Force-induced stabilisation of α-actinin at syndecan-4 enriched adhesions may result 
in recruitment of other essential adhesion components such as zyxin, vinculin and β1 integrins, to establish 
cell contraction and downstream syndecan-4 mechanosignalling. Beyond its function to sustain tension across 
syndecan-4 adhesions, α-actinin may also have direct additional roles in signalling, or indirectly as a force-
sensitive scaffold via recruitment of other signalling proteins. 
Syndecan-4-mediated force transduction was also found to activate YAP, a major transcriptional 
regulator and mechanosensor that relays mechanical and cytoskeletal signals to the nucleus. We demonstrate 
that syndecan-4-mediated tension at the cell-ECM interface is required for nuclear shuttling and activation of 
YAP and subsequent transcription of downstream YAP target genes. Low matrix tension or attenuated 
syndecan-4 mechanosignalling causes cytoplasmic YAP retention. The fact that the syndecan-4 null phenotype 
displays largely deactivated YAP and repressed YAP transcriptional signalling indicates a requirement for 
ECM ligation and mechanosignalling via both integrins and syndecan-4 to fully activate YAP. The syndecan-
4 null phenotype has a distinct cytoskeletal architecture with defects in microfilament assembly and an absence 
of F-actin stress fibres5,7, as well as impairments in focal adhesion assembly5,8. Presumably, deactivated YAP 
in syndecan-4 null cells is secondary to lower cytoskeletal tension, owing to deficits in F-actin stress fibre 
formation and destabilisation of cell-matrix adhesions resulting in decreased RhoA signalling and YAP 
activity.  
Interestingly, a recent study demonstrated a direct kindlin-2-RhoA signalling axis that senses 
mechanical cues from the cell microenvironment to control YAP and mesenchymal stem cell differentiation9. 
Since syndecan-4 knockout also results in phenotypic disturbances and secondary cytoskeletal impairments5, 
we speculate that the mechanical activation of YAP downstream of syndecan-4 may be linked to a RhoA-
mediated increase in overall cytoskeletal tension and stress fibre assembly, leaving the possibility for a similar 
kindlin-2-RhoA axis. 
The broader implications for this force-dependent regulation of β1 integrin activity in stromal 
fibroblasts downstream of syndecan-4 have yet to be established but likely extend to other cellular processes. 
For example, fibronectin has binding sites for both integrins and syndecans and a growing body of studies has 
revealed actomyosin generated forces transmitted through members of the β1 integrin family play a critical 
role in fibronectin fibrillogenesis10. Also, syndecan family members have been shown to play a role in the 
architectural regulation of the matrix microenvironment, potentially creating favourable niches for directional 
migration and cancer metastasis11. Thus, stromal syndecan-4 mechanotransduction may modulate the program 
of fibronectin fibrillogenesis, matrix assembly and overall ECM organisation by regulating integrin-mediated 
adhesion and actomyosin contraction with important implications for connective tissue homeostasis in health 
and disease. A stiff fibrotic matrix is a major clinical finding in most solid tumours. While the role of integrin-
mediated mechanosignalling has been the subject of intense investigation in the field of cancer 
mechanobiology in recent years, a more integrative approach that includes syndecan-4 as a key mechanosensor 
could pave the way for novel insights into disease mechanisms. 
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Supplementary Methods 
Western blotting 
Immediately after treatment, cell lysates were prepared in radio immunoprecipitation assay (RIPA) buffer 
(Sigma-Aldrich R0278) containing protease inhibitors (Sigma-Aldrich 4693124001) and phosphatase 
inhibitors (Sigma-Aldrich 4906837001). Cell lysates were centrifuged at 16,000 ×g for 20 min, and protein 
concentration was quantified using a BCA protein assay kit (Fisher Scientific 10678484). In order to resolve 
syndecan-4 in western blots, heparan sulphate chains were removed through enzymatic digestion. 100 µg total 
protein was methanol precipitated and suspended in buffer containing 50 mM HEPES, 50 mM NaOAc, 150 
mM NaCl, 5 mM CaCl2, ph 6.5 with 4×10-3 IU ml-1 heparinase I and 2.6 IU ml-1 heparinase III (Sigma-Aldrich 
H3917) for 4 h at 37°C with gentle rotation. Lysate was mixed with 4× Laemmli sample buffer including β-
mercaptoethanol, heated at 95°C for 5 min, and 10-20 µg loaded into each well of a 4-20% gel (Mini-
PROTEAN TGX, Bio-Rad). For analysis of adhesion complex, cell lysates were prepared from 25 cm2 flasks 
in 1% IGEPAL CA-630 (Sigma I8896), 150 mM NaCl, 50 mM Tris, pH 8 buffer containing EDTA-free 
protease inhibitors (Sigma 11836170001) and phosphatase inhibitors. Following rotation at 4°C for 25 min, 
beads were isolated from the cell lysate using a magnet. Beads were washed 3 times in lysis buffer and 
suspended in 2× Laemmli sample buffer containing β-mercaptoethanol, heated at 95°C for 5 min, and bead 
complex loaded into a 4-20% gel alongside whole cell lysate controls. Separated proteins were transferred onto 
nitrocellulose membrane (Bio-Rad). Total protein was assessed using Ponceau S stain (Sigma-Aldrich). 
Following removal of Ponceau S, blots were blocked in Odyssey Blocking Buffer in Tris buffered saline (TBS; 
Li-Cor) for 1 h. Blots were incubated with primary antibodies diluted in TBS-tween 20 (TBST) at 4°C 
overnight. Following washes in TBST, blots were incubated with IRDye 680RD or IRDye 800CW conjugated 
donkey anti-mouse or donkey anti-rabbit secondary antibodies (Li-Cor) at 1:15,000 in TBST for 1 h. After 
washing in TBST, blots were imaged using an Odyssey infrared imager. Quantification of protein bands was 
carried out using Image Studio Lite 5.2 (Li-Cor). Primary antibodies: rabbit anti-β-tubulin (1:5,000; Abcam 
ab15568; RRID:AB_2210952), mouse anti-α-actinin 4, clone G-4 (1:500, Santa Cruz Biotechnology sc-
390205; RRID:AB_2797388) and rabbit anti-syndecan-4 (1:500 Abcam ab24511; RRID:AB_448112). 
Uncropped blots are presented in Supplementary Figure 23. 
Supplementary References 
1 Hammond, G. R., Sim, Y., Lagnado, L. & Irvine, R. F. Reversible binding and rapid diffusion of proteins 
in complex with inositol lipids serves to coordinate free movement with spatial information. J Cell Biol 
184, 297-308 (2009). 
2 del Rio, A. et al. Stretching single talin rod molecules activates vinculin binding. Science 323, 638-641 
(2009). 
3 Bass, M. D. & Humphries, M. J. Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor 
and growth factor receptor signalling. Biochem. J. 368, 1-15 (2002). 
4 Greene, D. K., Tumova, S., Couchman, J. R. & Woods, A. Syndecan-4 associates with alpha-actinin. J. 
Biol. Chem. 278, 7617-7623 (2003). 
5 Okina, E., Grossi, A., Gopal, S., Multhaupt, H. A. & Couchman, J. R. Alpha-actinin interactions with 
syndecan-4 are integral to fibroblast-matrix adhesion and regulate cytoskeletal architecture. Int. J. 
Biochem. Cell Biol. 44, 2161-2174 (2012). 
6 Sjoblom, B., Salmazo, A. & Djinovic-Carugo, K. Alpha-actinin structure and regulation. Cell Mol Life Sci 
65, 2688-2701 (2008). 
7 Gopal, S. et al. Heparan sulfate chain valency controls syndecan-4 function in cell adhesion. J. Biol. Chem. 
285, 14247-14258 (2010). 
8 Cavalheiro, R. P. et al. Coupling of vinculin to F-actin demands Syndecan-4 proteoglycan. Matrix Biol. 
63, 23-37 (2017). 
9 Guo, L. et al. Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ. J 
Cell Biol 217, 1431-1451 (2018). 
10 Schwarzbauer, J. E. & DeSimone, D. W. Fibronectins, their fibrillogenesis, and in vivo functions. Cold 
Spring Harb Perspect Biol 3, 1-19 (2011). 
11 Yang, N., Mosher, R., Seo, S., Beebe, D. & Friedl, A. Syndecan-1 in breast cancer stroma fibroblasts 
regulates extracellular matrix fiber organization and carcinoma cell motility. Am J Pathol 178, 325-335 
(2011). 
This is a post-peer-review, pre-copyedit version of an article published in Nature Materials. The final authenticated 
version is available at: https://doi.org/10.1038/s41563-019-0567-1
